Literature DB >> 699981

Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphine.

R Horowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 699981     DOI： 10.1016/0014-2999(78)90340-0

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN： 0014-2999            Impact factor:   4.432


× No keyword cloud information.
  10 in total

1.  Hypothermic action of lisuride in rats and differences to bromocriptine in the antagonistic effect of neuroleptics.

Authors:  R Horowski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

Review 2.  The motor effects of bromocriptine--a review.

Authors:  D M Jackson; O F Jenkins; S B Ross
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

Review 3.  Hypothesis: bromocriptine lacks intrinsic dopamine receptor stimulating properties.

Authors:  D M Jackson; O F Jenkins
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

4.  Low dose lisuride in advanced Parkinson disease.

Authors:  F Degl'Innocenti; A Ginanneschi; S Magnolfi; L Catarzi; P Marini
Journal:  Ital J Neurol Sci       Date:  1987-08

5.  The use of lisuride, a potent dopamine and serotonin agonist, in the treatment of progressive supranuclear palsy.

Authors:  A Neophytides; A N Lieberman; M Goldstein; G Gopinathan; M Leibowitz; J Bock; R Walker
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-03       Impact factor: 10.154

6.  Binding of antiparkinsonian ergot derivatives to the dopamine receptor.

Authors:  R L Weir; R E Hruska; E K Silbergeld
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors.

Authors:  D M Jackson; M Hashizume
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

8.  Effectiveness of the dopamine agonist lisuride in the treatment of acromegaly and pathological hyperprolactinemic states.

Authors:  G Verde; P G Chiodini; A Liuzzi; R Cozzi; F Favales; L Botalla; B Spelta; D Dalla Bonzana; E Rainer; R Horowski
Journal:  J Endocrinol Invest       Date:  1980 Oct-Dec       Impact factor: 4.256

9.  The role of dopaminergic receptors in the behavioral effects induced by lisuride in male rats.

Authors:  G Baggio; F Ferrari
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

10.  Effects of lisuride on body temperature of rats and rabbits: relation to microsomal biotransformation and dopaminergic receptor stimulation.

Authors:  M O Carruba; S Ricciardi; J Negreanu; M Calogero; P Mantegazza
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.